D. J. Hoban

3.8k total citations
75 papers, 2.6k citations indexed

About

D. J. Hoban is a scholar working on Molecular Medicine, Pharmacology and Epidemiology. According to data from OpenAlex, D. J. Hoban has authored 75 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Medicine, 39 papers in Pharmacology and 34 papers in Epidemiology. Recurrent topics in D. J. Hoban's work include Antibiotic Resistance in Bacteria (45 papers), Antibiotics Pharmacokinetics and Efficacy (39 papers) and Pneumonia and Respiratory Infections (24 papers). D. J. Hoban is often cited by papers focused on Antibiotic Resistance in Bacteria (45 papers), Antibiotics Pharmacokinetics and Efficacy (39 papers) and Pneumonia and Respiratory Infections (24 papers). D. J. Hoban collaborates with scholars based in Canada, United States and United Kingdom. D. J. Hoban's co-authors include George G. Zhanel, James A. Karlowsky, Andrew Walkty, Philippe Lagacé‐Wiens, Kimberly A. Nichol, M. Roussel‐Delvallez, G V Doern, Ronald N. Jones, S. Bouchillon and Heather J. Adam and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Clinical Microbiology and The Journal of Infectious Diseases.

In The Last Decade

D. J. Hoban

74 papers receiving 2.4k citations

Peers

D. J. Hoban

EPIDE

PHARM

Evelio J. Perea Spain

Demei Zhu China

Dee Shortridge United States

Kevin Shannon United Kingdom

Lütfiye Mülazımoğlu Türkiye

Yuxing Ni China

Deniz Gür Türkiye

Kimberly A. Nichol Canada

Glenn A. Pankuch United States

Pattarachai Kiratisin Thailand

Evelio J. Perea Spain

D. J. Hoban

1.2k ×0.9

880 ×0.8

EPIDE

704 ×0.8

PHARM

485 ×0.8

403 ×1.0

Citations per year, relative to D. J. Hoban D. J. Hoban (= 1×) peers Evelio J. Perea

Countries citing papers authored by D. J. Hoban

Since Specialization

Citations

This map shows the geographic impact of D. J. Hoban's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. J. Hoban with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. J. Hoban more than expected).

Fields of papers citing papers by D. J. Hoban

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. J. Hoban. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. J. Hoban. The network helps show where D. J. Hoban may publish in the future.

Co-authorship network of co-authors of D. J. Hoban

This figure shows the co-authorship network connecting the top 25 collaborators of D. J. Hoban. A scholar is included among the top collaborators of D. J. Hoban based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. J. Hoban. D. J. Hoban is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lagacé‐Wiens, Philippe, Heather J. Adam, Nancy M. Laing, et al.. (2017). Antimicrobial susceptibility of clinical isolates of Neisseria gonorrhoeae to alternative antimicrobials with therapeutic potential. Journal of Antimicrobial Chemotherapy. 72(8). 2273–2277. 27 indexed citations

Biedenbach, Douglas J., et al.. (2014). In vitro activity of tigecycline and comparators against carbapenem-resistant Enterobacteriaceae in Africa–Middle East countries: TEST 2007–2012. Journal of Global Antimicrobial Resistance. 2(3). 179–182. 10 indexed citations

Bouchillon, S., et al.. (2014). In vitro activity of tigecycline against isolates collected from complicated skin and skin structure infections and intra-abdominal infections in Africa and Middle East countries: TEST 2007–2012. Diagnostic Microbiology and Infectious Disease. 79(1). 54–59. 21 indexed citations

Zhanel, George G., et al.. (2014). Pharmacodynamic activity of ertapenem versus genotypically characterized extended-spectrum -lactamase (ESBL)-, KPC- or NDM-producing Escherichia coli with reduced susceptibility or resistance to ertapenem using an in vitro model. Journal of Antimicrobial Chemotherapy. 69(9). 2448–2452. 9 indexed citations

Nichol, Kimberly A., Heather J. Adam, D. Roscoe, et al.. (2013). Changing epidemiology of methicillin-resistant Staphylococcus aureus in Canada. Journal of Antimicrobial Chemotherapy. 68(suppl 1). i47–i55. 38 indexed citations

Zhanel, George G., Heather J. Adam, Melanie Baxter, et al.. (2013). Antimicrobial susceptibility of 22746 pathogens from Canadian hospitals: results of the CANWARD 2007-11 study. Journal of Antimicrobial Chemotherapy. 68(suppl 1). i7–i22. 118 indexed citations

Hawser, Stephen, D. J. Hoban, S. Bouchillon, et al.. (2010). Antimicrobial susceptibility of intra-abdominal Gram-negative bacilli from Europe: SMART Europe 2008. European Journal of Clinical Microbiology & Infectious Diseases. 30(2). 173–179. 37 indexed citations

Noreddin, Ayman, et al.. (2007). Comparative pharmacodynamics of garenoxacin, gemifloxacin, and moxifloxacin in community-acquired pneumonia caused by Streptococcus pneumoniae: A Monte Carlo simulation analysis. Clinical Therapeutics. 29(12). 2685–2689. 7 indexed citations

Nichol, Kimberly A., et al.. (2006). Molecular epidemiology of urinary tract isolates of vancomycin-resistant Enterococcus faecium from North America. International Journal of Antimicrobial Agents. 27(5). 392–396. 27 indexed citations

10.

Zhanel, George G., et al.. (2006). Pharmacodynamic activity of ertapenem versus penicillin-susceptible and penicillin-non-susceptible Streptococcus pneumoniae using an in vitro model. Journal of Antimicrobial Chemotherapy. 59(1). 144–147. 3 indexed citations

11.

Johnson, J., et al.. (2005). Abstracts cont.. Clinical Microbiology and Infection. 11. 238–390. 1 indexed citations

12.

Hoban, D. J., S. Bouchillon, Jack Johnson, et al.. (2001). Comparative In Vitro Potency of Gemifloxacin and Fluoroquinolones Against Recent European Clinical Isolates from a Global Surveillance Study. European Journal of Clinical Microbiology & Infectious Diseases. 20(11). 814–819. 13 indexed citations

13.

Bandak, Stephen I., et al.. (2001). Antimicrobial susceptibilities of clinical isolates of Haemophilus influenzae and Moraxella catarrhalis collected during 1999–2000 from 13 countries. Clinical Microbiology and Infection. 7(12). 671–677. 18 indexed citations

14.

Bandak, Stephen I., et al.. (2001). Antibiotic Susceptibilities Among Recent Clinical Isolates of Haemophilus influenzae and Moraxella catarrhalis from Fifteen Countries. European Journal of Clinical Microbiology & Infectious Diseases. 20(1). 55–60. 18 indexed citations

15.

Hoban, D. J., et al.. (2001). Worldwide Prevalence of Antimicrobial Resistance inStreptococcus pneumoniae, Haemophilus influenzae,andMoraxella catarrhalisin the SENTRY Antimicrobial Surveillance Program, 1997–1999. Clinical Infectious Diseases. 32(s2). S81–S93. 323 indexed citations

16.

Karlowsky, James A., Geetika Verma, George G. Zhanel, & D. J. Hoban. (2000). Presence of ROB-1 -lactamase correlates with cefaclor resistance among recent isolates of Haemophilus influenzae. Journal of Antimicrobial Chemotherapy. 45(6). 871–875. 27 indexed citations

17.

Madani, Tariq A., et al.. (1998). Value of routine procurement of Isolator in addition to BacT/Alert blood cultures in febrile neutropenic patients with acute myeloid leukemia. 9(5). 287–293. 1 indexed citations

18.

Hoban, D. J., et al.. (1992). In-vitro activity of streptogramin RP 59500 against staphylococci, including bactericidal kinetic studies. Journal of Antimicrobial Chemotherapy. 30(suppl A). 59–65. 23 indexed citations

19.

Al‐Qattan, Mohammad M., M.F. Stranc, Mario Jarmuske, & D. J. Hoban. (1989). Wound sterilization: CO2 laser versus iodine. British Journal of Plastic Surgery. 42(4). 380–384. 9 indexed citations

20.

Hoban, D. J.. (1989). In-vitro activity of a new penem FCE 22101. Journal of Antimicrobial Chemotherapy. 23(suppl C). 53–57. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact